{"id":2628,"date":"2019-10-22T14:21:58","date_gmt":"2019-10-22T18:21:58","guid":{"rendered":"http:\/\/localhost:10028\/whitepapers\/law360-quotes-hunter-shkolnik-on-48b-opioid-deal\/"},"modified":"2022-06-27T02:33:53","modified_gmt":"2022-06-27T06:33:53","slug":"prawo360-cytaty-hunter-szkolnik-on-48b-opioid-deal","status":"publish","type":"whitepapers","link":"https:\/\/napolilaw.lemonadestand.org\/pl\/biale-papiery\/prawo360-cytaty-hunter-szkolnik-on-48b-opioid-deal\/","title":{"rendered":"Law360 cytuje Huntera Shkolnika w sprawie umowy dotycz\u0105cej opioid\u00f3w $48B"},"content":{"rendered":"<p>A rapid outburst of opposition to a $48 billion &#8220;settlement framework&#8221; in opioid-crisis litigation unveiled Monday by four state attorneys general may signal a shift to local governments and states fighting not only with drug companies but also with each other.<\/p>\n<p>The backlash from plaintiffs lawyers in the opioid multidistrict litigation and at least one other state attorney general emerged immediately as the attorneys general of Texas, Tennessee, North Carolina and Pennsylvania announced a $48 billion settlement framework with Cardinal Health Inc., McKesson Corp., AmerisourceBergen Corp., Teva Pharmaceuticals and Johnson &amp; Johnson.<\/p>\n<p>&#8220;It&#8217;s the deal that we all rejected&#8221; on Friday, said Hunter Shkolnik of Napoli Shkolnik PLLC, referring to the early reaction when the framework&#8217;s details leaked last week. &#8220;That deal is dead on arrival.&#8221;<\/p>","protected":false},"excerpt":{"rendered":"<p>Gwa\u0142towny wybuch sprzeciwu wobec \u201eramy rozliczeniowej\u201d o warto\u015bci $48 miliard\u00f3w w sporach s\u0105dowych dotycz\u0105cych kryzysu opioidowego, ujawnionych w poniedzia\u0142ek przez czterech prokurator\u00f3w generalnych, mo\u017ce sygnalizowa\u0107 przej\u015bcie do samorz\u0105d\u00f3w lokalnych i stan\u00f3w\u2026<\/p>","protected":false},"featured_media":0,"menu_order":255,"template":"","whitepaper_category":[75,253,254],"whitepaper-source":[63],"class_list":["post-2628","whitepapers","type-whitepapers","status-publish","hentry","whitepaper_category-opioids-litigation","whitepaper_category-opioid-crisis","whitepaper_category-opioid-epidemic","whitepaper-source-law360"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/whitepapers\/2628","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/whitepapers"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/types\/whitepapers"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/whitepapers\/2628\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/media?parent=2628"}],"wp:term":[{"taxonomy":"whitepaper_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/whitepaper_category?post=2628"},{"taxonomy":"whitepaper-source","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/whitepaper-source?post=2628"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}